438 related articles for article (PubMed ID: 28043395)
21. [Further comment on the role of sugars for the successful infection of blood-sucking Diptera by protozoa that are the causative agents of human diseases].
Alekseev AN
Parazitologiia; 1990; 24(5):396-9. PubMed ID: 2259528
[TBL] [Abstract][Full Text] [Related]
22. Transmission-Blocking Potential of MEFAS, a Hybrid Compound Derived from Artesunate and Mefloquine.
Penna-Coutinho J; Almela MJ; Miguel-Blanco C; Herreros E; Sá PM; Boechat N; Krettli AU
Antimicrob Agents Chemother; 2016 May; 60(5):3145-7. PubMed ID: 26902763
[TBL] [Abstract][Full Text] [Related]
23. The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg).
Dow G; Smith B
Malar J; 2017 May; 16(1):209. PubMed ID: 28526056
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
[TBL] [Abstract][Full Text] [Related]
25. Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.
Aguiar AC; Figueiredo FJ; Neuenfeldt PD; Katsuragawa TH; Drawanz BB; Cunico W; Sinnis P; Zavala F; Krettli AU
Malar J; 2017 Mar; 16(1):110. PubMed ID: 28279180
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium gallinaceum preferentially invades vesicular ATPase-expressing cells in Aedes aegypti midgut.
Shahabuddin M; Pimenta PF
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3385-9. PubMed ID: 9520375
[TBL] [Abstract][Full Text] [Related]
27. Antimalarial compounds: from bench to bedside.
Olliaro PL; Taylor WR
J Exp Biol; 2003 Nov; 206(Pt 21):3753-9. PubMed ID: 14506210
[TBL] [Abstract][Full Text] [Related]
28. Malaria parasite development in a Drosophila model.
Schneider D; Shahabuddin M
Science; 2000 Jun; 288(5475):2376-9. PubMed ID: 10875925
[TBL] [Abstract][Full Text] [Related]
29. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
Stewart LB; Peters W; Robinson BL
Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
[TBL] [Abstract][Full Text] [Related]
30. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
31. Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites.
Pollitt LC; Huijben S; Sim DG; Salathé RM; Jones MJ; Read AF
PLoS Pathog; 2014 Apr; 10(4):e1004019. PubMed ID: 24763470
[TBL] [Abstract][Full Text] [Related]
32. Assessment
Yipsirimetee A; Chiewpoo P; Tripura R; Lek D; Day NPJ; Dondorp AM; Pukrittayakamee S; White NJ; Chotivanich K
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0148121. PubMed ID: 34978886
[TBL] [Abstract][Full Text] [Related]
33. A method for screening drugs against the liver stages of malaria using Plasmodium gallinaceum and Aedes mosquitos.
Carvalho LH; Ferrari WM; Krettli AU
Braz J Med Biol Res; 1992; 25(3):247-55. PubMed ID: 1341921
[TBL] [Abstract][Full Text] [Related]
34. Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.
Tanaka TQ; Guiguemde WA; Barnett DS; Maron MI; Min J; Connelly MC; Suryadevara PK; Guy RK; Williamson KC
Antimicrob Agents Chemother; 2015 Mar; 59(3):1389-97. PubMed ID: 25512421
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum.
Ramharter M; Noedl H; Thimasarn K; Wiedermann G; Wernsdorfer G; Wernsdorfer WH
Am J Trop Med Hyg; 2002 Jul; 67(1):39-43. PubMed ID: 12363062
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium gallinaceum: mosquito peritrophic matrix and the parasite-vector compatibility.
Shahabuddin M; Kaidoh T; Aikawa M; Kaslow DC
Exp Parasitol; 1995 Nov; 81(3):386-93. PubMed ID: 7498435
[TBL] [Abstract][Full Text] [Related]
37. The role of anti-malarial drugs in eliminating malaria.
White NJ
Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S8. PubMed ID: 19091042
[TBL] [Abstract][Full Text] [Related]
38. Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children.
Sowunmi A; Balogun T; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA
Antimicrob Agents Chemother; 2007 May; 51(5):1694-9. PubMed ID: 17325222
[TBL] [Abstract][Full Text] [Related]
39. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
40. Isonicotinic acid hydrazide: an anti-tuberculosis drug inhibits malarial transmission in the mosquito gut.
Arai M; Alavi YI; Mendoza J; Billker O; Sinden RE
Exp Parasitol; 2004; 106(1-2):30-6. PubMed ID: 15013786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
